approval · primary record
DARATUMUMAB AND HYALURONIDASE-FIHJ
FDA · BLA · 2026-02-12
| Agency | FDA |
|---|---|
| Submission type | BLA |
| Action date | 2026-02-12 |
| Brand | DARZALEX FASPRO |
| Sponsor | JANSSEN BIOTECH |
| Route | INJECTION |
Provenance
- Source: openFDA Drugs@FDA
- Fetched at: 2026-10-28T03:31:17.012Z
- Licence class: public-domain
- Verdict: primary-source
- Entity id: FDA:DARATUMUMAB AND HYALURONIDASE-FIHJ:2026-02-12
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.